Prevention of relapse by mesalazine (Pentasa®) in pediatric Crohn's disease: A multicenter, double-blind, randomized, placebo-controlled trial-Reference-Cited by-同舟云学术

Prevention of relapse by mesalazine (Pentasa®) in pediatric Crohn's disease: A multicenter, double-blind, randomized, placebo-controlled trial

Published:2009-01 Issue:1 Volume:33 Page:31-40
ISSN:0399-8320
Container-title:Gastroentérologie Clinique et Biologique
language:en
Short-container-title:Gastroentérologie Clinique et Biologique

Author:

Cezard J.-P.,Munck A.,Mouterde O.,Morali A.,Lenaerts C.,Lachaux A.,Turck D.,Schmitz J.,Maurage C.,Girardet J.-P.,Belli D.,Lamireau T.,Sarles J.,Chouraqui J.-P.,Descos B.,Dabadi A.,Meyer M.,Olives J.-P.,Mary J.-Y.

Publisher

Elsevier BV

Subject

Gastroenterology,General Medicine

Reference27 articles.

1. Incidence of inflammatory bowel disease in northern France (1988–1990);Gower-Rousseau;Gut,1994

2. Identifying patients with a high risk of relapse in quiescent Crohn's disease;Sahmoud;Gut,1995

3. Maladie de Crohn;Cézard,2000

4. Growth and clinical course of children with Crohn's disease;Griffiths;Gut,1993

5. Growth in paediatric Crohn's disease;Cezard;Horm Res,2002

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consenso colombiano de la enfermedad inflamatoria intestinal pediátrica;Revista colombiana de Gastroenterología;2023-10-02

2. Inflammatory Bowel Disease in Children;Indian Journal of Pediatrics;2023-06-20

3. Medical management of pediatric inflammatory bowel disease in the Asia‐Pacific region: A position paper by the Asian Pan‐Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition (APPSPGHAN) PIBD Working Group;Journal of Gastroenterology and Hepatology;2023-01-10

4. 5-Aminosalicylate Therapy;Pediatric Inflammatory Bowel Disease;2023

5. Pediatric Management of Crohn’s Disease;Gastroenterology Clinics of North America;2022-06